Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: healthadmin
There are probably more tiny plastic debris in the Yakima River than you expected. This is a first-of-its-kind study.Researchers from Central Washington University sampled nine sites in the Yakima River. Samples were taken from Snoqualmie Pass all the way to the mouth of the Tri-Cities. Clay Arango, a professor of biological sciences at the university, said this kind of research had not been done before in rivers.Plastic fibers were present in every location the researchers sampled, even near the source. Arango said most sample areas detected between 2.5 and 5 pieces of debris per liter.”Who would have thought there would…
Modern neuroscience often describes the brain as a collection of specialized systems. Functions such as attention, perception, memory, language, and reasoning are each associated with specific brain networks, and scientists have typically studied these systems separately. This approach has led to significant advances. However, a central feature of human thinking – how all these separate systems come together to form a single unified mind – is not fully explained. Researchers at the University of Notre Dame decided to address this question. They used advanced neuroimaging to examine how the brain is organized as a whole and how that organization produces…
Pfizer CEO Dr. Albert Bourla, one of the most influential voices in the biopharmaceutical industry, has harshly criticized FDA Director Vinay Prasad, MD, and his work as director of the Center for Biologics Evaluation and Research (CBER), which regulates vaccines in the United States. “We have a problem with the leadership at CBER,” Bourla said Monday at the TD Cowen Healthcare Conference. “I don’t think the current director is following the recommendations of the staff.” The rebuke was in response to questions about Pfizer’s interactions with the FDA regarding the vaccine. The company is one of the world’s most prolific…
Grow Therapy, a hybrid mental health provider, wins $150 million to build physician-employer relationships. The Series D round was led by TCV and Goldman Sachs Alternatives Growth Equity, with participation from new investors BCI and Menlo Ventures. Physicians and employers are a new customer type for Grow, but they have been the focus of the platform’s growth over the past five years. The funding will also be used to enhance the technology behind Grow and improve the user experience for patients, therapists, and other partners. Grow currently has a wide range of partners including 125 payers, provider groups such as…
Bones fractured in (skiing) accidents often repair without medical intervention. However, if the fracture is particularly severe or a bone tumor needs to be surgically removed, doctors will rely on implants to stabilize the area and support new bone growth. Today’s implants are typically made from the patient’s own bone, called an autograft, or from metal or ceramic materials. Autografts require additional surgery to harvest bone tissue, which increases recovery time and surgical risks. Problems can arise because metal implants are much harder than natural bone and can loosen over time, reducing long-term stability. Biologically compatible bone implant design Bones…
Asexual women tend to prioritize different characteristics in their partners compared to heterosexual women
New research published in Sexual behavior archives It turns out that asexual women seek emotionally intimate relationships, but they tend to prefer nontraditional settings like platonic relationships over traditional monogamy. This finding highlights how expectations for intimacy and partnership follow different paths when sexual desire is not the primary factor. Asexuality is generally defined as feeling little or no sexual attraction to others. Importantly, many asexual people still experience a strong desire for emotional intimacy, so a lack of sexual attraction does not necessarily mean a lack of romantic attraction. The authors of the new study sought to better understand…
An international team of scientists has discovered that albumin, the most abundant protein circulating in human blood, plays a powerful, previously unrecognized role in protecting the body from mucormycosis, a rare but often fatal fungal infection. The survey results are nature. The research was led by Dr. George Chamilos and his team at the University of Crete and the Institute of Molecular Biology and Biotechnology, with key contributions from a group at the Lundquist Institute for Biomedical Innovation led by Professor Ashraf Ibrahim. Mucormycosis, also known as “black fungus”, is caused by fungi of the order Mucorales and spreads rapidly…
Welcome to this week’s Chutes & Ladders. A summary of hiring, firing, and retirement events across the industry. please submit We’ll feature good news or bad news from your shop here every week. Week of March 2nd> health tech companies star health Added raul smitha veteran of Elevance Health, has been named chief financial officer. Mr. Smith has 20 years of experience in healthcare leadership, including six years as president and CFO of Anthem’s East region, according to the announcement. He also served as CFO for Duo Health and Gold Kidney Health Plan. Stella said Smith’s experience in the health…
A Hungarian study found that people who dislike dark comedy tended to feel less anxious and negative when exposed to light humor, but more anxious when exposed to dark humor. After watching humorous videos, people most often reported lower levels of both positive and negative emotions. This study Individuality and individual differences. Humor is the ability to perceive, create, or appreciate funny or absurd situations. It often works by defying expectations in harmless ways, such as surprise, irony, exaggeration, and wordplay. One influential explanation, the “benign violation” theory, suggests that something is funny when it violates norms, but when it…
The FDA has provided further insight into recent rejections submitted to two major pharmaceutical companies, releasing complete response letters (CRLs) sent to AstraZeneca and GSK, highlighting gaps in data included in the application packages. In a scathing rebuke (PDF) to AstraZeneca, the FDA cited “significant data quality issues impacting key analyzes including the primary endpoint” in the dataset for Safnero (anifrolumab), which is proposed for use in systemic lupus erythematosus (SLE). Separately, the agency rejected GSK’s Exdensur (depemokimab) for chronic sinusitis with nasal polyps (CRSwNP) (PDF), ruling that clinical data failed to provide “sufficient evidence” of efficacy and cast doubt…